Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin? | Zendy

Denice S. Feig | Zendy; Bernard Zinman | Zendy; Elizabeth Asztalos | Zendy; Lois Donovan | Zendy; Prakesh S. Shah | Zendy; Johanna Sanchez | Zendy; George Tomlinson | Zendy; Kellie E. Murphy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin?

Author(s) -

Denice S. Feig,

Bernard Zinman,

Elizabeth Asztalos,

Lois Donovan,

Prakesh S. Shah,

Johanna Sanchez,

George Tomlinson,

Kellie E. Murphy

Publication year - 2022

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc22-0013

Subject(s) - metformin , medicine , small for gestational age , comorbidity , type 2 diabetes , placebo , pregnancy , odds ratio , diabetes mellitus , gestational diabetes , obstetrics , endocrinology , gestational age , gestation , alternative medicine , pathology , biology , genetics

In the MiTy (Metformin in Women With Type 2 Diabetes in Pregnancy) randomized trial of metformin versus placebo added to insulin, we found numerous benefits with metformin but identified an increased proportion of infants who were small for gestational age (SGA). We aimed to determine the predictors of SGA in order to individualize care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research